Cargando…

Delayed payment schemes in Central-Eastern Europe and Middle-East

The need for innovative payment models for health technologies with high upfront costs has emerged due to affordability concerns across the world. Early technology adopter countries have been experimenting with delayed payment schemes. Our objective included listing potential barriers for implementi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ádám, Ildikó, Callenbach, Marcelien, Németh, Bertalan, Vreman, Rick A., Pontén, Johan, Strbad, Tea, Dawoud, Dalia, Kostyuk, Alexander, Seyam, Ahmed, Nagy, László, Goettsch, Wim G., Kaló, Zoltán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411855/ https://www.ncbi.nlm.nih.gov/pubmed/36035424 http://dx.doi.org/10.3389/fmed.2022.940371

Ejemplares similares

When Reality Does Not Meet Expectations—Experiences and Perceived Attitudes of Dutch Stakeholders Regarding Payment and Reimbursement Models for High-Priced Hospital Drugs
por: Callenbach, Marcelien H. E., et al.
Publicado: (2022)

Outcome-based reimbursement in Central-Eastern Europe and Middle-East
por: Ádám, Ildikó, et al.
Publicado: (2022)

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making
por: Németh, Bertalan, et al.
Publicado: (2023)

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer
por: Tesar, Tomas, et al.
Publicado: (2017)

Real World Data in Health Technology Assessment of Complex Health Technologies
por: Hogervorst, Milou A., et al.
Publicado: (2022)

Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment
por: Zemplényi, Antal, et al.
Publicado: (2023)

Can cost–effectiveness principles be ignored in urgent times?
por: Kaló, Zoltán, et al.
Publicado: (2021)

Synergy between health technology assessments and clinical guidelines for multiple sclerosis
por: Hogervorst, Milou A., et al.
Publicado: (2023)

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries
por: Tachkov, Konstantin, et al.
Publicado: (2022)

Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries
por: Dimitrova, Maria, et al.
Publicado: (2022)

Decision Making Under Uncertainty: Comparing Regulatory and Health Technology Assessment Reviews of Medicines in the United States and Europe
por: Vreman, Rick A., et al.
Publicado: (2020)

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries
por: Jakab, Ivett, et al.
Publicado: (2023)

Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?
por: Kovács, Sándor, et al.
Publicado: (2022)

Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis
por: A Vreman, Rick, et al.
Publicado: (2020)

Bridging the gap: Can International Consortium of Health Outcomes Measurement standard sets align outcomes accepted for regulatory and health technology assessment decision‐making of oncology medicines
por: Kalf, Rachel R. J., et al.
Publicado: (2021)

Staff Insurance Scheme Indexation of Pensions in Payment
Publicado: (1974)

Staff Insurance Scheme Indexation of Pensions in Payment
Publicado: (1975)

Staff Insurance Scheme Indexation of Pensions in Payment
Publicado: (1973)

Staff Insurance Scheme Indexation of Pensions in Payment
Publicado: (1974)

Staff Insurance Scheme Indexation of Pensions in Payment
Publicado: (1973)

The Prospects for Payment for Ecosystem Services (PES) in Vietnam: A Look at Three Payment Schemes
por: To, Phuc Xuan, et al.
Publicado: (2012)

Non-invasive detection of hypovolemia or fluid responsiveness in spontaneously breathing subjects
por: Zöllei, Éva, et al.
Publicado: (2013)

A utility of model input uncertainty analysis in transferring tobacco control‐related economic evidence to countries with scarce resources: results from the EQUIPT study
por: Németh, Bertalan, et al.
Publicado: (2018)

Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses
por: Jakab, Ivett, et al.
Publicado: (2020)

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia
por: Vreman, Rick A., et al.
Publicado: (2019)

The Application and Implications of Novel Deterministic Sensitivity Analysis Methods
por: Vreman, Rick A., et al.
Publicado: (2020)

Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges
por: Federici, Carlo, et al.
Publicado: (2021)

Promoting habitual mobile payment usage via the Thai government's 50:50 co-payment scheme
por: Boonsiritomachai, Waranpong, et al.
Publicado: (2023)

Physician altruism under the change from pure payment system to mixed payment schemes: experimental evidence
por: Zhang, Yue, et al.
Publicado: (2023)

Payment scheme for student travel - ADMI, DOCT, TECH, Graduates
Publicado: (2019)

Staff Insurance Scheme - Indexation of Pensions in Payment Additional Information
Publicado: (1976)

Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
por: McQueen, R. Brett, et al.
Publicado: (2022)

Weighing of Evidence by Health Technology Assessment Bodies: Retrospective Study of Reimbursement Recommendations for Conditionally Approved Drugs
por: Vreman, Rick A., et al.
Publicado: (2018)

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia
por: Inotai, Andras, et al.
Publicado: (2018)

Effectiveness of Nusinersen in Type 1, 2 and 3 Spinal Muscular Atrophy: Croatian Real-World Data
por: Belančić, Andrej, et al.
Publicado: (2023)

A concept for multi-winner tenders for medicinal products with balancing between efficient prices, long-term competition and sustainability of supply
por: Németh, Gergely, et al.
Publicado: (2023)

Perspectives on how to build bridges between regulation, health technology assessment and clinical guideline development: a qualitative focus group study with European experts
por: Hogervorst, Milou A, et al.
Publicado: (2023)

How payment scheme affects patients’ adherence to medications? A systematic review
por: Aziz, Hamiza, et al.
Publicado: (2016)

Outcome-Based Payment Schemes: What Outcomes Do Patients with Cancer Value?
por: Lorgelly, Paula, et al.
Publicado: (2020)

Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia
por: Lorenzovici, László, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0m0jg6a6c1vksk7i7tqs9up6pk